Zobrazeno 1 - 10
of 17
pro vyhledávání: '"A Birgitta, Versluijs"'
Autor:
Annalisa Ruggeri, Nicole Santoro, Jacques-Emmanuel Galimard, Krzysztof Kalwak, Mattia Algeri, Ludmila Zubarovskaya, Krzysztof Czyzewski, Elena Skorobogatova, Petr Sedlacek, Caroline Besley, Adriana Balduzzi, Yves Bertrand, Julia Peristeri, Franca Fagioli, Mariane Ifversen, Jolanta Gozdzik, Christina Peters, Birgitta Versluijs, Alessandra Biffi, Arcangelo Prete, Maura Faraci, Ibrahim Ghemlas, Ivana Bodova, Olga Aleinikova, Arnaud Dalissier, Vanderson Rocha, Selim Corbacioglu
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
In children with acute myeloid leukemia (AML) who lack an HLA identical sibling, the donor can be replaced with an HLA matched unrelated donor (MUD) or a haploidentical donor (haplo). We compared outcomes of patients
Externí odkaz:
https://doaj.org/article/0cbd8179ddf14c39a5bebdf419f8d1ed
Autor:
Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow, Alexander Kiani, Manuela Krumbholz, Maaike Luesink, Nora Naumann-Bartsch, Barbara De Moerloose, Michael Osborn, Kirk R. Schultz, Petr Sedlacek, Fiorina Giona, Christian Michel Zwaan, Hiroyuki Shimada, Birgitta Versluijs, Frederic Millot, Nobuko Hijiya, Meinolf Suttorp, Markus Metzler
Publikováno v:
LEUKEMIA
Treatment of chronic myeloid leukemia has improved significantly with the introduction of tyrosine kinase inhibitors (TKIs), and treatment guidelines based on numerous clinical trials are available for chronic phase disease. However for CML in the bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b05378b4f6d8078f18afd531508cadb
http://www.scopus.com/inward/record.url?scp=85146931008&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85146931008&partnerID=8YFLogxK
Autor:
Rick, Admiraal, Stefan, Nierkens, Marc B, Bierings, Robbert G M, Bredius, Ineke, van Vliet, Yilin, Jiang, Marta, Lopez-Yurda, A Birgitta, Versluijs, C Michel, Zwaan, Caroline A, Lindemans, Jaap Jan, Boelens
Publikováno v:
The Lancet Haematology, 9(2), e111-e120. Lancet Publishing Group
Background: Anti-thymocyte globulin, which is used in the conditioning of haematopoietic stem-cell transplantation (HSCT) to prevent graft-versus-host disease (GVHD) and graft failure, has highly variable pharmacokinetics. Overexposure to anti-thymoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41c9f6d5007004ab5ec065beb7dfc0d
https://doi.org/10.1016/s2352-3026(21)00375-6
https://doi.org/10.1016/s2352-3026(21)00375-6
Autor:
Wouter J.W. Kollen, Jaap Jan Boelens, Caroline A. Lindemans, Arjan C. Lankester, Birgitta Versluijs, Dorine Bresters, Coco de Koning, Marc Bierings, Stefan Nierkens
Publikováno v:
Blood Advances, 6(6), 1719-1730. ELSEVIER
We prospectively studied clofarabine-fludarabine-busulfan (CloFluBu)-conditioning in allogeneic hematopoietic cell therapy (HCT) for lymphoid and myeloid malignancies and hypothesized that CloFluBu provides a less toxic alternative to conventional co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6483d664f0196a7bd75269bfcf33d4e1
http://hdl.handle.net/1887/3575907
http://hdl.handle.net/1887/3575907
Autor:
Roelie M. Wösten-van Asperen, Martine van Grotel, Josephus P. J. van Gestel, Joppe Nijman, Mila van Dorst, Birgitta Versluijs, Marry M. van den Heuvel-Eibrink
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:e1-e6
The use of high-flow nasal cannula (HFNC) oxygen therapy is growing as an alternative to standard oxygen. However, its use in patients treated for malignancies, including hematopoietic stem cell transplantation (HSCT) patients, is controversial. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789c0de97a2815fd1422872cbe271478
https://doi.org/10.1097/mph.0000000000001649
https://doi.org/10.1097/mph.0000000000001649
Autor:
Andromachi Scaradavou, Maria Cancio, Celina L. Szanto, Mirjam E. Belderbos, Elizabeth Klein, Wouter J.W. Kollen, Farid Boulad, Nancy A. Kernan, Dorine Bresters, Marc Bierings, Stefan Nierkens, Kevin J. Curran, Barbara Spitzer, Coco de Koning, Jurgen Langenhorst, Jaap Jan Boelens, Birgitta Versluijs, Caroline A. Lindemans, Susan E. Prockop, Alwin D. R. Huitema, Ichelle van Roessel, Richard J. O'Reilly
Publikováno v:
Blood
Acute graft-versus-host-Disease (aGVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). We previously showed that early CD4+ T-cell immune reconstitution (IR; CD4+ IR) predicts survival after HCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5555c041f4a96722046831f6ef4a6558
https://europepmc.org/articles/PMC7986048/
https://europepmc.org/articles/PMC7986048/
Autor:
C. Michel Zwaan, Rutger R. G. Knops, Gertjan J.L. Kaspers, Raphaële R. L. van Litsenburg, Wim J. E. Tissing, Birgitta Versluijs, Natasja Dors, Marry M. van den Heuvel-Eibrink, Kim Klein, Valerie de Haas, Emily Risa Schwartz
Publikováno v:
Blood. 138:2293-2293
Introduction Together with considerable improvement in diagnostics and supportive care measures, treatment intensification has contributed to the improvement of pediatric acute myeloid leukemia (AML) survival outcomes. However, treatment-related toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afa983327cdf9d64276639736859614
https://doi.org/10.1182/blood-2021-149851
https://doi.org/10.1182/blood-2021-149851
Autor:
Marina Borisevich, Stéphanie Ragot, Guy Leverger, Birgitte Lausen, Birgitta Versluijs, Frédéric Millot, Meinolf Suttorp, Jean-Hugues Dalle
Publikováno v:
Blood. 136:53-54
Background: Imatinib, a tyrosine kinase inhibitor (TKI) is currently proposed as first line therapy in children with chronic myeloid leukemia (CML) in chronic phase (CP). Studies in adults with CML demonstrated that 40 to 50% of patients with prolong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::211d84d2b3f72b0bd813510d4ac77d6e
https://doi.org/10.1182/blood-2020-135844
https://doi.org/10.1182/blood-2020-135844
Autor:
Marc Bierings, Jaap-Jan Boelens, Christian M. Zwaan, Stefan Nierkens, Ineke van Vliet, A. Birgitta Versluijs, Robbert G. M. Bredius, Rick Admiraal, Caroline A. Lindemans, Marta Lopez Yurda
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S33-S34
Introduction Rabbit anti-thymocyte globulin (ATG) is used in allogeneic hematopoietic cell transplantation (HCT) to prevent graft-versus-host-disease (GvHD) and graft failure (GF). Its main and unpredictable toxicity includes poor immune reconstituti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e8269a0ca4d13cff891e005c7240008
https://doi.org/10.1016/j.bbmt.2019.12.577
https://doi.org/10.1016/j.bbmt.2019.12.577
Autor:
Andre J Vlot, Martine Raphael, L Thom Vlasveld, Tessa M. A. Peters, A. Birgitta Versluijs, Alexander J. Rennings, Dorine W. Swinkels, Bert van den Heuvel, Mirian C. H. Janssen, Frank L. van de Veerdonk, Michel van Gelder, Dirk L Bakkeren, Charlotte C.M. Schaap, Bernd Granzen, Anita W. Rijneveld, Paul P. T. Brons, V.M.J. Novotny, Albertine E. Donker, Inge M. Appel, R.J.H. Smeets, M.R. Nijziel
Publikováno v:
American Journal of Hematology, 91, E482-e490
Donker, A E, Schaap, C C M, Novotny, V M J, Smeets, R, Peters, T M A, van den Heuvel, B L P, Raphael, M F, Rijneveld, A W, Appel, I M, Vlot, A J, Versluijs, A B, van Gelder, M, Granzen, B, Janssen, M C H, Rennings, A J M, van de Veerdonk, F L, Brons, P P T, Bakkeren, D L, Nijziel, M R, Vlasveld, L T & Swinkels, D W 2016, ' Iron refractory iron deficiency anemia : a heterogeneous disease that is not always iron refractory ', American Journal of Hematology, vol. 91, no. 12, pp. E482-E490 . https://doi.org/10.1002/ajh.24561
American Journal of Hematology, 91(12), E482-E490. Wiley-Liss Inc.
American Journal of Hematology, 91(12), E482-E490. Wiley
American Journal of Hematology, 91, 12, pp. E482-e490
American Journal of Hematology, 91(12), E482. Wiley-Liss Inc.
American Journal of Hematology
Donker, A E, Schaap, C C M, Novotny, V M J, Smeets, R, Peters, T M A, van den Heuvel, B L P, Raphael, M F, Rijneveld, A W, Appel, I M, Vlot, A J, Versluijs, A B, van Gelder, M, Granzen, B, Janssen, M C H, Rennings, A J M, van de Veerdonk, F L, Brons, P P T, Bakkeren, D L, Nijziel, M R, Vlasveld, L T & Swinkels, D W 2016, ' Iron refractory iron deficiency anemia : a heterogeneous disease that is not always iron refractory ', American Journal of Hematology, vol. 91, no. 12, pp. E482-E490 . https://doi.org/10.1002/ajh.24561
American Journal of Hematology, 91(12), E482-E490. Wiley-Liss Inc.
American Journal of Hematology, 91(12), E482-E490. Wiley
American Journal of Hematology, 91, 12, pp. E482-e490
American Journal of Hematology, 91(12), E482. Wiley-Liss Inc.
American Journal of Hematology
Contains fulltext : 172863.pdf (Publisher’s version ) (Open Access) TMPRSS6 variants that affect protein function result in impaired matriptase-2 function and consequently uninhibited hepcidin production, leading to iron refractory iron deficiency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c6f12a5b6673fe7c428bdf9490acd6
https://hdl.handle.net/1765/97141
https://hdl.handle.net/1765/97141